The U.S. Food and Drug Administration (FDA) says that adult regenerative cells are ‘biologic products’, and since it is a patients’ own blood, component, or therapeutic serum, it is “applicable to prevention, treatment or cure of a condition or disease in human beings.” They are also allowed for athletes who compete, as they are one’s own native tissues.  Thus, regenerative cells and platelets do not require oversight and are not regulated by the FDA . They are of low risk as they are comprised of one’s own human blood and bone-marrow  products.

mm
Latest posts by John Urse, DO (see all)

Pin It on Pinterest

Share This